On November 19th, BGI, in collaboration with Shenzhen Women Entrepreneurs Association, Shenzhen Women's Physician Association, Shenzhen Women and Children's Development Foundation, and Shenzhen Radio and Television Public Welfare Foundation jointly launched the Shenzhen Women's Awa...
On July 8, BGI announced in Beijing that it would launch the “10 million families away from genetic birth defects” program. The program has launched a series of "technical public welfare" projects for rare diseases, including the "Ziqi Plan" for patients with mucopolysaccharidosis, the "Spring Un...
On June 24th, BGI launched the “Ziqi Plan” which is part of BGI’s Using Genomics Technology to TreatRare Diseases Program, providing free HLA bone marrow matching testing services for 100 mucopolysaccharidosis patients. The Plan enables the public to further understand the relationship between ge...
On June 12th, the Women's Health Action and Free Cervical Cancer Screening Campaign, jointly organized by BGI and the Fenghuang County Government, was officially launched. It plans to provide cervical cancer screening for more than 50,000 married women at a childbearing age in the period 201...
On January 8th, BGI has received 30 child patients for HLA high-resolution genotyping testing in Huizhou.
On January 25th, the Chinese Red Cross Society awarded BGI Research (now "BGI Life Science Research") the Red Cross medal - the highest honor of the Red Cross.